Qingsong Health was incorporated.

Qingsong Health completed series A investment and series A+ investment in August 2015 and November 2015, respectively, with an aggregate proceeds of US$3.6 million raised.

Qingsong Health completed series B investment and series B+ investment in January 2016 and June 2016, respectively, with an aggregate proceeds of US$17.2 million raised.

Qingsong Health successfully sold our first online insurance policy and launched our Qingsong Insurance services in December 2016.

Qingsong Health completed series C investment February 2017, with an aggregate proceeds of US$22.8 million raised.

Qingsong Health launched integrated health service package for enterprise and individual customers in November 2017

Qingsong Health completed series C-1 investment in March 2018.

Qingsong Health teamed up with Guofu Life Insurance Co., Ltd. to create the first provincial-level supplementary health insurance Huiminbao Program in August 2020.

Qingsong Health completed series D investment May 2020, with an aggregate proceed of US$66,000,000 raised.

Qingsong Health were successfully selected as one of 2022 Cases for Healthy China Innovative Practices (Health Responsibility) by People’s Health of People’s Daily Online in December 2022.

Qingsong Health，as a pioneer, developed the “Xiannv α” large model system based on the MaaS industry model in July 2023.

Qingsong Health launched our market education services in July 2023.

Qingsong Health launched medical research assistance services in 2024 and started to provide real-world data study services for our Qingsong Healthcare services in February 2024.

Qingsong Health together with the Health Client of People’s Daily jointly launched the 7th “Famous Doctors of China—the 6630 Communication Campaign for the Improvement of Public Health Literacy”in June 2024.